The veterinary pharmaceutical industry operates at the intersection of rigorous science, strict regulatory oversight, and competitive commercial pressure. Companies developing antiparasitic drugs, vaccines, antibiotics, and pain management products for animals must navigate FDA Center for Veterinary Medicine (CVM) approval processes, maintain pharmacovigilance documentation, and simultaneously manage relationships with distributors, veterinary clinics, and agricultural producers.
According to the Animal Health Institute, the U.S. animal health industry — with pharmaceuticals as a major component — generated over $14 billion in sales in 2023. That scale creates immense administrative burden, and an increasing number of companies are turning to virtual assistants to absorb it.
Regulatory Affairs Support That Scales
One of the most time-intensive functions inside a veterinary pharmaceutical company is regulatory affairs documentation management. New Animal Drug Applications (NADAs), Abbreviated New Animal Drug Applications (ANADAs), and Generic Investigational New Animal Drug (GINAD) submissions each require extensive file organization, timeline tracking, and correspondence management with FDA reviewers.
While the regulatory affairs professionals themselves must hold scientific credentials and make substantive decisions about submission strategy, much of the surrounding coordination work does not require that expertise. VAs can maintain submission deadline calendars, organize response files, track comment periods on proposed rule changes from the Federal Register, and prepare meeting agendas for regulatory review sessions — freeing the credentialed staff for actual scientific work.
Sales and Distributor Relationship Management
Veterinary pharmaceutical companies typically sell through national distributors like Covetrus and MWI Veterinary Supply, as well as direct to large veterinary groups. Each distributor relationship generates consistent administrative traffic: order inquiries, pricing schedule updates, promotional material distribution, and co-op marketing coordination.
VAs assigned to support field sales representatives handle CRM data hygiene after sales calls, send follow-up materials to clinic contacts, and schedule product detail meetings with veterinary practices. According to a Salesforce State of Sales report, sales reps spend an average of 28 percent of their time on administrative tasks. For veterinary pharma reps managing large territories, a dedicated VA can recover that time and redirect it toward selling activities.
Pharmacovigilance and Adverse Event Coordination
Post-market surveillance is a regulatory requirement for approved veterinary drugs. Companies must collect adverse event reports, maintain case files, and submit periodic safety update reports to the FDA. VAs trained in pharmacovigilance intake workflows can handle the initial data collection from clinic-reported cases, organize files into the appropriate reporting formats, and flag cases requiring veterinary toxicologist review.
This is not about replacing the scientific judgment required for safety evaluation — it is about ensuring that the administrative infrastructure around pharmacovigilance is organized and responsive so that credentialed staff spend their time on analysis, not paperwork logistics.
The Financial Case for VA Deployment
Pharmaceutical administrative coordinators in the U.S. earn between $50,000 and $70,000 annually depending on specialization and location. Benefits, training, and office costs add another 25 to 30 percent on top of salary. Virtual assistants offering comparable administrative capability can be engaged at a significantly lower total cost, with the flexibility to scale coverage across time zones and project phases.
For veterinary pharmaceutical companies ready to build efficient administrative infrastructure without proportionally growing their in-house headcount, Stealth Agents offers virtual assistants with experience in life sciences support, regulatory documentation coordination, and sales operations who can integrate into your existing systems quickly.
As the veterinary pharmaceutical pipeline continues to expand — driven by new antiparasitic resistance profiles, companion animal oncology treatments, and precision livestock medicine — the companies that will move fastest are those with operations that can scale efficiently alongside their scientific ambitions.
Sources
- Animal Health Institute, AHI 2023 Animal Health Sales and Production Report
- U.S. Food and Drug Administration, FDA Center for Veterinary Medicine: New Animal Drug Applications, 2023
- Salesforce, State of Sales Report, 5th Edition, 2022